1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SLC2A9 CTRPv2 pan-cancer AAC 0.097 0.009
mRNA MAGED4 CTRPv2 pan-cancer AAC -0.1 0.009
mRNA INPP4B CTRPv2 pan-cancer AAC 0.099 0.009
mRNA EXOSC9 CTRPv2 pan-cancer AAC -0.099 0.009
mRNA NANOS1 CTRPv2 pan-cancer AAC 0.092 0.009
mRNA SAP30 CTRPv2 pan-cancer AAC -0.11 0.009
mRNA NBPF1 CTRPv2 pan-cancer AAC -0.095 0.009
mRNA RNPEP CTRPv2 pan-cancer AAC 0.094 0.009
mRNA NPL CTRPv2 pan-cancer AAC 0.091 0.009
mRNA RAB27A CTRPv2 pan-cancer AAC 0.099 0.009
Download CSV